Failure of Short-Course Ceftriaxone Chemotherapy for Multidrug-Resistant Typhoid Fever in Children: a Randomized Controlled Trial in Pakistan

AUTOR(ES)

Bhutta, Zulfiqar A.

FONTE

American Society for Microbiology

RESUMO

The precise duration of therapy of multidrug-resistant (MDR) typhoid with broad-spectrum cephalosporins is uncertain. We prospectively randomized 57 children with culture-proven MDR typhoid to receive treatment with intravenous ceftriaxone (CRO) (65 mg/kg of body weight/day) for 7 days (short course; n = 29) or 14 days (conventional; n = 28). The response to therapy, as evaluated by the serial monitoring of the typhoid morbidity score and bacteriological clearance, was comparable between groups. In contrast to the conventional therapy, 14% of the children receiving CRO for 7 days had a confirmed bacteriological relapse within 4 weeks of stopping therapy.

Documentos Relacionados

• Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.
• Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.
• Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children.
• A Randomized Controlled Comparison of Azithromycin and Ofloxacin for Treatment of Multidrug-Resistant or Nalidixic Acid-Resistant Enteric Fever
• Urology—Important Advances in Clinical Medicine: Short-Course Chemotherapy for Genitourinary Tuberculosis